A detailed history of Washington Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Washington Trust CO holds 125,178 shares of ABT stock, worth $14.3 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
125,178
Previous 127,439 1.77%
Holding current value
$14.3 Million
Previous $14.5 Million 10.2%
% of portfolio
0.48%
Previous 0.54%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$100.73 - $112.44 $227,750 - $254,226
-2,261 Reduced 1.77%
125,178 $13 Million
Q1 2024

Apr 23, 2024

SELL
$109.52 - $120.96 $93,201 - $102,936
-851 Reduced 0.66%
127,439 $14.5 Million
Q4 2023

Jan 18, 2024

SELL
$90.19 - $110.4 $43,471 - $53,212
-482 Reduced 0.37%
128,290 $14.1 Million
Q3 2023

Oct 18, 2023

BUY
$95.53 - $114.62 $71,360 - $85,621
747 Added 0.58%
128,772 $12.5 Million
Q2 2023

Jul 27, 2023

BUY
$100.78 - $112.29 $122,850 - $136,881
1,219 Added 0.96%
128,025 $14 Million
Q1 2023

May 10, 2023

BUY
$96.86 - $114.01 $12.3 Million - $14.5 Million
126,802 Added 99844.09%
126,929 $12.9 Million
Q1 2023

May 04, 2023

SELL
$96.86 - $114.01 $12.3 Million - $14.4 Million
-126,679 Reduced 99.9%
127 $12.9 Million
Q4 2022

Jul 27, 2023

SELL
$95.06 - $111.52 $11,692 - $13,716
-123 Reduced 0.1%
126,806 $13.9 Million
Q4 2022

Feb 08, 2023

SELL
$95.06 - $111.52 $295,731 - $346,938
-3,111 Reduced 2.39%
126,806 $13.9 Million
Q3 2022

Oct 14, 2022

SELL
$96.76 - $112.03 $43,348 - $50,189
-448 Reduced 0.34%
129,917 $12.6 Million
Q2 2022

Jul 25, 2022

BUY
$102.07 - $123.37 $404,809 - $489,285
3,966 Added 3.14%
130,365 $14.2 Million
Q1 2022

May 05, 2022

BUY
$114.02 - $139.04 $1.01 Million - $1.23 Million
8,850 Added 7.53%
126,399 $15 Million
Q4 2021

Feb 09, 2022

SELL
$115.53 - $141.46 $3.32 Million - $4.06 Million
-28,721 Reduced 19.64%
117,549 $16.5 Million
Q3 2021

Nov 09, 2021

SELL
$116.66 - $129.06 $56,930 - $62,981
-488 Reduced 0.33%
146,270 $17.3 Million
Q2 2021

Aug 05, 2021

BUY
$105.79 - $124.53 $280,131 - $329,755
2,648 Added 1.84%
146,758 $17 Million
Q1 2021

Apr 28, 2021

BUY
$108.84 - $128.23 $45,821 - $53,984
421 Added 0.29%
144,110 $17.3 Million
Q4 2020

Feb 09, 2021

BUY
$105.0 - $114.42 $2,205 - $2,402
21 Added 0.01%
143,689 $15.7 Million
Q3 2020

Nov 05, 2020

SELL
$91.64 - $111.29 $191,710 - $232,818
-2,092 Reduced 1.44%
143,668 $15.6 Million
Q2 2020

Aug 04, 2020

SELL
$76.57 - $98.0 $966,619 - $1.24 Million
-12,624 Reduced 7.97%
145,760 $13 Million
Q1 2020

May 07, 2020

BUY
$62.82 - $91.86 $350,849 - $513,038
5,585 Added 3.66%
158,384 $12.5 Million
Q4 2019

Feb 12, 2020

BUY
$78.51 - $87.4 $2.15 Million - $2.39 Million
27,352 Added 21.8%
152,799 $13.3 Million
Q3 2019

Nov 06, 2019

SELL
$81.84 - $88.74 $478,682 - $519,040
-5,849 Reduced 4.45%
125,447 $10.5 Million
Q2 2019

Aug 07, 2019

BUY
$72.88 - $85.0 $82,281 - $95,965
1,129 Added 0.87%
131,296 $11 Million
Q1 2019

May 13, 2019

SELL
$66.22 - $80.06 $479,499 - $579,714
-7,241 Reduced 5.27%
130,167 $9.92 Million
Q4 2018

Feb 11, 2019

SELL
$65.56 - $74.27 $147,378 - $166,958
-2,248 Reduced 1.61%
137,408 $9.94 Million
Q3 2018

Nov 13, 2018

BUY
$60.81 - $73.36 $443,669 - $535,234
7,296 Added 5.51%
139,656 $10.2 Million
Q2 2018

Aug 10, 2018

BUY
$57.57 - $63.54 $897,170 - $990,207
15,584 Added 13.35%
132,360 $8.07 Million
Q1 2018

May 10, 2018

SELL
$56.27 - $63.62 $178,488 - $201,802
-3,172 Reduced 2.64%
116,776 $7 Million
Q4 2017

Feb 05, 2018

BUY
$53.68 - $57.47 $35,804 - $38,332
667 Added 0.56%
119,948 $6.84 Million
Q3 2017

Oct 31, 2017

BUY
$48.06 - $53.64 $5.73 Million - $6.4 Million
119,281
119,281 $6.37 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Washington Trust CO Portfolio

Follow Washington Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust CO with notifications on news.